Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George P Canellos

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Seminars in Hematology|March 16, 2005
Lymphoma: present and future challengesGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Chemotherapy alone for early Hodgkin's lymphoma: an emerging optionGeorge P Canellos
Hematology/Oncology Clinics of North America|October 3, 2007
Relapsed and refractory Hodgkin's lymphoma: new avenues?George P Canellos
The Oncologist|December 17, 2009
Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option?George P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
New treatments for advanced Hodgkin's disease: an uphill fight beginning close to the topGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful?George P Canellos
Oncology (Williston Park, N.Y.)|February 19, 2013
Treatment for favorable localized Hodgkin lymphoma: the final answer is awaitedGeorge P Canellos
The Oncologist|April 15, 2006
Introduction to a special series of unique entities within the spectrum of large-cell lymphomaGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
What constitutes "improved prognosis"?George P Canellos
European Journal of Haematology. Supplementum|July 13, 2005
Clinical trials in North AmericaGeorge P Canellos
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Seminars in Hematology|March 16, 2005
Lymphoma: present and future challengesGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Chemotherapy alone for early Hodgkin's lymphoma: an emerging optionGeorge P Canellos
Hematology/Oncology Clinics of North America|October 3, 2007
Relapsed and refractory Hodgkin's lymphoma: new avenues?George P Canellos
The Oncologist|December 17, 2009
Is chemotherapy alone for early Hodgkin lymphoma an emerging therapeutic option?George P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
New treatments for advanced Hodgkin's disease: an uphill fight beginning close to the topGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful?George P Canellos
Oncology (Williston Park, N.Y.)|February 19, 2013
Treatment for favorable localized Hodgkin lymphoma: the final answer is awaitedGeorge P Canellos
The Oncologist|April 15, 2006
Introduction to a special series of unique entities within the spectrum of large-cell lymphomaGeorge P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
What constitutes "improved prognosis"?George P Canellos
European Journal of Haematology. Supplementum|July 13, 2005
Clinical trials in North AmericaGeorge P Canellos
Pageof 4